InflaRx N.V.

NASDAQ:IFRX

Biotechnology

Healthcare
$1.09 -0.82%

-$0.02 today

Market cap
$160.63M
Beta
2.44
P/E (TTM)
-2.7
EPS (TTM)
-$0.59
52W Low $0.74High $2.95

Volume 0.66M

Average 1.80M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$33.92M

FY 2025 · Annual

Investing Cash Flow

$3.11M

FY 2025 · Annual

-94.1% YoY

Financing Cash Flow

$32.00M

FY 2025 · Annual

+8181.0% YoY

Cash Flow Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(45.63M)(29.48M)(42.67M)(46.06M)(43.83M)
Depreciation & Amortization669.43K596.6K567.78K485.11K402.93K
Deferred Income Tax1.16M0000
Stock-Based Compensation4.33M6.04M3.41M4.07M0
Change in Working Capital1.54M(9.77M)1M(2.28M)4.66M
Accounts Receivables00002.12M
Inventory00(11.37M)4.47M6.63M
Accounts Payables316.11K(3.52M)00(5.76M)
Other Working Capital1.22M(6.25M)12.37M(6.75M)1.68M
Other Non-Cash Items(2M)(1.13M)(131.29K)(4.76M)4.84M
Operating Cash Flow(39.94M)(33.74M)(37.81M)(48.56M)(33.92M)
Capital Expenditures(37.78K)(162.39K)(81.1K)(46.87K)(111.13K)
Acquisitions (Net)37.78K(19.52M)000
Purchases of Investments(97.52M)(64.47M)(104.05M)(35.34M)(44.28M)
Sales of Investments71.6M84M86.44M87.75M47.5M
Other Investing Activities(37.78K)19.52M01(3)
Investing Cash Flow(25.95M)19.36M(17.7M)52.36M3.11M
Debt Repayment(360.64K)(364.43K)(373.98K)(388.11K)(357.58K)
Common Stock Issued65.14M2.35M56.48M1.1M32.35M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(3.2M)(47.74K)(3.12M)(323.73K)14.11K
Financing Cash Flow61.58M1.94M52.99M386.45K32M
Effect of Forex Changes4.59M2.46M(974.1K)1.41M(1.37M)
Net Change in Cash281.31K(9.98M)(3.5M)5.61M(179.66K)
Free Cash Flow(39.97M)(33.91M)(37.89M)(48.6M)(34.03M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$43.8M
+ D&A$402.9K
+ Stock-Based Comp$0
+ Deferred Tax$0
+ Working Capital$4.7M
+ Other Non-Cash$4.8M
= Operating Cash Flow-$33.9M
- Capex-$111.1K
= Free Cash Flow-$34.0M

Analysis

FY2025 free cash flow is -$34.0M. FCF conversion is 77.6% of net income. Operating cash flow was -$33.9M, with capex of -$111.1K. The largest bridge item is Other Non-Cash at $4.8M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 6, 2026
6-K6-K filingNov 3, 2026
6-K6-K filingNov 3, 2026
6-K6-K filingOct 22, 2026
SC 13GSC 13G filingAug 17, 2026

Does IFRX generate free cash flow?

InflaRx N.V. (IFRX) generated -$34.03M of free cash flow in fiscal 2025.

How much operating cash flow does IFRX produce?

Operating cash flow was -$33.92M, before capital expenditures of $111,127.00.